Valuation: CTCBIO Inc.

Market Cap 73.16B 53.94M 47.6M 45.04M 40.85M 76.58M 5.18B 77.34M 540M 208M 2.64B 203M 198M 8.51B P/E 2024
-30x
P/E 2025 34.1x
Enterprise Value 94.19B 69.45M 61.29M 57.99M 52.59M 98.6M 6.66B 99.57M 696M 268M 3.4B 261M 255M 10.95B EV / Sales 2024
1.18x
EV / Sales 2025 1.06x
Free-Float
48.02%
Yield 2024 *
-
Yield 2025 -
1 day+0.33%
Current month-1.13%
1 month-0.97%
3 months+10.47%
6 months-22.43%
Current year-33.84%
1 week 2,960
Extreme 2960
3,075
1 month 2,960
Extreme 2960
3,165
Current year 2,570
Extreme 2570
4,775
1 year 2,570
Extreme 2570
6,280
3 years 2,570
Extreme 2570
12,210
5 years 2,570
Extreme 2570
15,900
10 years 2,570
Extreme 2570
17,800
Manager TitleAgeSince
Chief Executive Officer 63 2024-04-17
Chief Executive Officer 61 2025-03-13
President 53 2023-03-30
Director TitleAgeSince
Director/Board Member 53 2021-12-19
Director/Board Member 41 2022-03-27
Director/Board Member 63 2024-04-17
Date Insider Type Main position Quantity % Market Cap. Importance
2/3/25 Sell 1,431,202 5.9187%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%0.00%-55.00%-73.41% 53.59M
-0.01%+1.24%+63.06%+120.55% 1,056B
-1.61%-0.60%+47.32%+71.79% 655B
-1.12%-0.72%+17.98%+76.63% 471B
-1.72%-4.25%+37.79%+39.89% 342B
-0.40%+4.12%+22.89%+29.04% 277B
-0.51%-1.05%+12.98%+12.92% 257B
+1.32%+3.27%+54.63%+57.63% 226B
-0.61%-0.91%+34.33%+101.87% 189B
-0.24%-3.21%-27.79%-61.37% 170B
Average -0.46%+0.46%+20.82%+37.55% 364.29B
Weighted average by Cap. -0.63%+0.76%+39.20%+70.62%

Financials

2024 2025
Net sales 144B 106M 93.96M 88.9M 80.62M 151M 10.22B 153M 1.07B 411M 5.22B 400M 391M 16.79B 124B 91.26M 80.53M 76.2M 69.1M 130M 8.76B 131M 914M 352M 4.47B 343M 335M 14.39B
Net income -5.22B -3.85M -3.4M -3.21M -2.91M -5.46M -369M -5.52M -38.55M -14.86M -189M -14.45M -14.14M -607M 3.24B 2.39M 2.11M 1.99M 1.81M 3.39M 229M 3.43M 23.93M 9.22M 117M 8.97M 8.78M 377M
Net Debt 13.7B 10.1M 8.91M 8.43M 7.65M 14.34M 969M 14.48M 101M 38.99M 495M 37.92M 37.1M 1.59B 21.03B 15.51M 13.69M 12.95M 11.74M 22.02M 1.49B 22.23M 155M 59.87M 760M 58.23M 56.96M 2.45B
Logo CTCBIO Inc.
CTC Bio Inc is a Korea-based company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. The Human Pharmaceuticals segment primarily manufactures and sells human pharmaceuticals, including improved new drugs, generics, and health functional foods. The Animal Pharmaceuticals segment manufactures and sells animal pharmaceuticals, including feed additives, disinfectants, and vaccines. The Company sells its products in domestic and overseas markets.
Employees
248
Date Price Change Volume
26-09-29 ₩3,060.00 +0.33% 40,664
26-09-28 ₩3,050.00 +1.50% 56,236
26-09-23 ₩3,005.00 -1.15% 46,886
26-09-22 ₩3,040.00 -0.65% 31,383
  1. Stock Market
  2. Stocks
  3. A060590 Stock